Genome-guided approaches and evaluation of the strategies to influence bioprocessing assisted morphological engineering of Streptomyces cell factories

Bioresour Technol. 2023 May;376:128836. doi: 10.1016/j.biortech.2023.128836. Epub 2023 Mar 9.


Streptomyces genera serve as adaptable cell factories for secondary metabolites with various and distinctive chemical structures that are relevant to the pharmaceutical industry. Streptomyces' complex life cycle necessitated a variety of tactics to enhance metabolite production. Identification of metabolic pathways, secondary metabolite clusters, and their controls have all been accomplished using genomic methods. Besides this, bioprocess parameters were also optimized for the regulation of morphology. Kinase families were identified as key checkpoints in the metabolic manipulation (DivIVA, Scy, FilP, matAB, and AfsK) and morphology engineering of Streptomyces. This review illustrates the role of different physiological variables during fermentation in the bioeconomy coupled with genome-based molecular characterization of biomolecules responsible for secondary metabolite production at different developmental stages of the Streptomyces life cycle.

Keywords: Anti-obesity drug; Bioprocess engineering; Microparticle enhanced cultivation; Morphology engineering; Pellet modulation.

Publication types

  • Review

MeSH terms

  • Genomics
  • Metabolic Networks and Pathways
  • Streptomyces* / genetics
  • Streptomyces* / metabolism